VTE case studies from a clinical nursing specialist team

Impact of an All Wales Hospital Acquired Thrombosis Steering Group

Stephane Jaglin and Andrea Croft

VTE Workshop

Emma Gee, Rachna Patel, Andrea Croft and Huw Rowswell

Implementation of a standardised annual anticoagulation specialist review in primary care

Nathan Hutchinson-Jones

Learning in VTE risk assessment

Professor Roopen Arya, Lara Roberts, Marc Blondon and Banne Nemeth

Identifying problem areas in thrombosis that need fresh ideas

Chaired by: Professor Beverley Hunt OBE(a) Where are we going to improve quality and safety of imaging for VTE? – Dr Narayan Karunanithy(b) Will we ever develop a perfect anticoagulant? – Professor Helen Philippou(c) Improving VTE risk assessment for thromboprophylaxis in UK hospitals – Professor Roopen Arya

Reducing hospital acquired thrombosis – Learning from NHS GIRFT (Getting It Right First Time)

Chaired by: Professor Roopen AryaGIRFT findings – Dr Lara RobertsLocal impact and changes implemented as a result of GIRFT – Andrew GillettPanel discussion and Q&A session – Dr Lara Roberts, Emma Gee, Rebecca Simpson, Andrew Gillett

VTE prevention in hospitalised psychiatric patients

Chaired by: Professor Beverley Hunt OBESpeakers: Dr Josie Jenkinson, Dr Thomas York, Dr Ashma Mohamed, Dr Michael Cheah

VACCINES AND BLOOD CLOTS

In this tutorial, Beverley introduces vaccine-induced immune thrombocytopenia and thrombosis syndrome, an extremely rare immune response to a vaccine causing thrombosis (blood clots) and thrombocytopenia (low platelet count), most commonly following the Astra-Zeneca vaccine.

BLOOD CLOTS IN ACUTE COVID-19 INFECTION

In this tutorial, Beverley discussed blood clots in acute COVID-19 infection, including who is at risk, the types of thrombosis seen, and what preventative measures are recommended for moderately and severely unwell patients.